Abstract:Precision biotransformation is an envisioned strategy offering detailed insights into biotransformation pathways in real environmental settings using experimentally guided high-accuracy quantum chemistry. Emerging pollutants, whose metabolites are easily overlooked but may cause idiosyncratic toxicity, are important targets of such a strategy. We demonstrate here that complex metabolic reactions of tris(1,3-dichloro-2-propyl) phosphate (TDCIPP) catalyzed by human CYP450 enzymes can be mapped via a three-step synergy strategy: (i) screening the possible metabolites via high-throughout (moderate-accuracy) computations; (ii) analyzing the proposed metabolites in vitro by human liver microsomes and recombinant human CYP450 enzymes; and (iii) rationalizing the experimental data via precise mechanisms using high-level targeted computations. Through the bilateral dialogues from qualitative to semi-quantitative to quantitative levels, we show how TDCIPP metabolism especially by CYP3A4 generates bis(1,3-dichloro-2-propyl) phosphate (BDCIPP) as an O-dealkylation metabolite and bis(1,3-dichloro-2-propyl) 3-chloro-1-hydroxy-2-propyl phosphate (alcoholβ-dehalogen) as a dehalogenation/reduction metabolite via the initial rate-determining H-abstraction from αC- and βC-positions. The relative yield ratio [dehalogenation/reduction]/[O-dealkylation] is derived from the relative barriers of H-abstraction at the βC- and αC-positions by CYP3A4, estimated as 0.002 to 0.23, viz., an in vitro measured ratio of 0.04. Importantly, alcoholβ-dehalogen formation points to a new mechanism involving successive oxidation and reduction functions of CYP450, with its precursor aldehydeβ-dehalogen being a key intermediate detected by trapping assays and rationalized by computations. We conclude that the proposed three-step synergy strategy may meet the increasing challenge of elucidating biotransformation mechanisms of substantial synthesized organic compounds in the future.

Microbial transformation of hydrophobic compound in cloud point system

Whole Cell Microbial Transformation in Cloud Point System

Cloud point system as a tool to improve the efficiency of biotransformation

A downstream process with microemulsion extraction for microbial transformation in cloud point system

Biotransformation of phytosterol to produce androsta-diene-dione by resting cells of Mycobacterium in cloud point system

Model of bioconversion of cholesterol in cloud point system

Extractive Microbial Fermentation in Cloud Point System

Precision Biotransformation of Emerging Pollutants by Human Cytochrome P450 Using Computational–Experimental Synergy: A Case Study of Tris(1,3-dichloro-2-propyl) Phosphate

In situ extraction of polar product of whole cell microbial transformation with polyethylene glycol-induced cloud point system.

A Closed Concept of Extractive Whole Cell Microbial Transformation of Benzaldehyde into l -Phenylacetylcarbinol by Saccharomyces cerevisiae in Novel Polyethylene-Glycol-Induced Cloud-Point System

Improvement the tolerance of baker's yeast to toxic substrate/product with cloud point system during the whole cell microbial transformation

Extractive Whole Cell Biotransformation In Cloud Point System

Aerobic Microbial Transformation of Fluorinated Liquid Crystal Monomer: New Pathways and Mechanism

Sterol Side-Chain Cleavage by Microbial Transformation

Two-phase Partitioning Bioreactor, Application of Cloud Point System in Bioconversion

Study on Conditions of Extractive Microbial Transformation to Produce L-phenylacetylcarbinol in Micelle Aqueous Solution

Investigation of Extractive Microbial Transformation in Nonionic Surfactant Micelle Aqueous Solution Using Response Surface Methodology.

Enhancing Stability and Formulation Capability of Fungicides by Cocrystallization Through a Novel Multistep Slurry Conversion Process

Assessing bioavailability of the solubilization of organic compound in nonionic surfactant micelles by dose–response analysis

Process development of transforming phytosterols to steroidal pharmaceutical intermediates by Mycolicibacterium neoaurum with L-carnitine

Nonionic Surfactant Mediated Cloud Point Extraction